Published on:

Court ruling could put spotlight on drug safety

A recent Supreme Court ruling that federal approval of a drug is no protection from product liability lawsuits in state courts could put heat on drugmakers. The product liability ruling could make pharmaceutical companies more cautious about safety issues, leading them to halt development of some medicines and pull others off of the market. The ruling upheld a $6.7 million jury verdict against a pharmaceutical company.

To read more about the Supreme Court product liability ruling.

To read the Supreme Court product liability opinion.